Table of Contents

2019-2024 Global Diabetes Injection Pens Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Diabetes Injection Pens Consumption 2014-2024
  • 2.1.2 Diabetes Injection Pens Consumption CAGR by Region
• 2.2 Diabetes Injection Pens Segment by Type
  • 2.2.1 Reusable Insulin Pens
  • 2.2.2 Disposable Insulin Pens
• 2.3 Diabetes Injection Pens Consumption by Type
  • 2.3.1 Global Diabetes Injection Pens Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Diabetes Injection Pens Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Diabetes Injection Pens Sale Price by Type (2014-2019)
• 2.4 Diabetes Injection Pens Segment by Application
  • 2.4.1 Hospital & Clinic
  • 2.4.2 Retail Pharmacy
  • 2.4.3 Online Sales
• 2.5 Diabetes Injection Pens Consumption by Application
  • 2.5.1 Global Diabetes Injection Pens Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Diabetes Injection Pens Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Diabetes Injection Pens Sale Price by Application (2014-2019)

3 Global Diabetes Injection Pens by Players

• 3.1 Global Diabetes Injection Pens Sales Market Share by Players
  • 3.1.1 Global Diabetes Injection Pens Sales by Players (2017-2019)
  • 3.1.2 Global Diabetes Injection Pens Sales Market Share by Players (2017-2019)
• 3.2 Global Diabetes Injection Pens Revenue Market Share by Players
  • 3.2.1 Global Diabetes Injection Pens Revenue by Players (2017-2019)
  • 3.2.2 Global Diabetes Injection Pens Revenue Market Share by Players (2017-2019)
• 3.3 Global Diabetes Injection Pens Sale Price by Players
• 3.4 Global Diabetes Injection Pens Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Diabetes Injection Pens Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Diabetes Injection Pens Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Diabetes Injection Pens by Regions

• 4.1 Diabetes Injection Pens by Regions
  • 4.1.1 Global Diabetes Injection Pens Consumption by Regions
  • 4.1.2 Global Diabetes Injection Pens Value by Regions
• 4.2 Americas Diabetes Injection Pens Consumption Growth
• 4.3 APAC Diabetes Injection Pens Consumption Growth
• 4.4 Europe Diabetes Injection Pens Consumption Growth
• 4.5 Middle East & Africa Diabetes Injection Pens Consumption Growth

5 Americas

• 5.1 Americas Diabetes Injection Pens Consumption by Countries
  • 5.1.1 Americas Diabetes Injection Pens Consumption by Countries (2014-2019)
  • 5.1.2 Americas Diabetes Injection Pens Value by Countries (2014-2019)
• 5.2 Americas Diabetes Injection Pens Consumption by Type
• 5.3 Americas Diabetes Injection Pens Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Diabetes Injection Pens Consumption by Countries
  • 6.1.1 APAC Diabetes Injection Pens Consumption by Countries (2014-2019)
  • 6.1.2 APAC Diabetes Injection Pens Value by Countries (2014-2019)
• 6.2 APAC Diabetes Injection Pens Consumption by Type
• 6.3 APAC Diabetes Injection Pens Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Diabetes Injection Pens by Countries
  • 7.1.1 Europe Diabetes Injection Pens Consumption by Countries (2014-2019)
  • 7.1.2 Europe Diabetes Injection Pens Value by Countries (2014-2019)
• 7.2 Europe Diabetes Injection Pens Consumption by Type
• 7.3 Europe Diabetes Injection Pens Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Diabetes Injection Pens by Countries
  • 8.1.1 Middle East & Africa Diabetes Injection Pens Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Diabetes Injection Pens Value by Countries (2014-2019)
• 8.2 Middle East & Africa Diabetes Injection Pens Consumption by Type
• 8.3 Middle East & Africa Diabetes Injection Pens Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Diabetes Injection Pens Distributors
• 10.3 Diabetes Injection Pens Customer

11 Global Diabetes Injection Pens Market Forecast

• 11.1 Global Diabetes Injection Pens Consumption Forecast (2019-2024)
• 11.2 Global Diabetes Injection Pens Forecast by Regions
  • 11.2.1 Global Diabetes Injection Pens Forecast by Regions (2019-2024)
  • 11.2.2 Global Diabetes Injection Pens Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Diabetes Injection Pens Forecast by Type
• 11.8 Global Diabetes Injection Pens Forecast by Application

12 Key Players Analysis

• 12.1 Novo Nordisk
  • 12.1.1 Company Details
  • 12.1.2 Diabetes Injection Pens Product Offered
  • 12.1.3 Novo Nordisk Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Novo Nordisk News
• 12.2 Eli Lilly
  • 12.2.1 Company Details
  • 12.2.2 Diabetes Injection Pens Product Offered
  • 12.2.3 Eli Lilly Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Eli Lilly News
• 12.3 Sanofi
  • 12.3.1 Company Details
  • 12.3.2 Diabetes Injection Pens Product Offered
  • 12.3.3 Sanofi Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Sanofi News
• 12.4 BD
  • 12.4.1 Company Details
  • 12.4.2 Diabetes Injection Pens Product Offered
  • 12.4.3 BD Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 BD News
• 12.5 Ypsomed Holding
  • 12.5.1 Company Details
  • 12.5.2 Diabetes Injection Pens Product Offered
  • 12.5.3 Ypsomed Holding Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Ypsomed Holding News
• 12.6 Dongbao
  • 12.6.1 Company Details
  • 12.6.2 Diabetes Injection Pens Product Offered
  • 12.6.3 Dongbao Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Dongbao News
• 12.7 Owen Mumford
  • 12.7.1 Company Details
  • 12.7.2 Diabetes Injection Pens Product Offered
  • 12.7.3 Owen Mumford Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Owen Mumford News
• 12.8 Ganlee
  • 12.8.1 Company Details
  • 12.8.2 Diabetes Injection Pens Product Offered
  • 12.8.3 Ganlee Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Ganlee News
• 12.9 Delfu
  • 12.9.1 Company Details
  • 12.9.2 Diabetes Injection Pens Product Offered
  • 12.9.3 Delfu Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Delfu News

13 Research Findings and Conclusion

Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
The classification of Diabetes Injection Pens includes Reusable Insulin Pens and Disposable Insulin Pens. The revenue proportion of Reusable Insulin Pens in 2017 is about 86%.
The sales channel for Diabetes Injection Pens is Hospital & Clinic, Retail Pharmacy and Online sales. Among these distribution channels, buying injection pens from Retail Pharmacy are more preferred, and this contributed to a share of nearly 60.0% to the global diabetes injection pens market as of 2017. Owing to the availability of a flourishing global e-commerce sector, the online channel is becoming much more noticeable.

According to this study, over the next five years the Diabetes Injection Pens market will register a 3.9% CAGR in terms of revenue, the global market size will reach US$ 4730 million by 2024, from US$ 3900 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diabetes Injection Pens business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Injection Pens market by product type, application, key manufacturers and key regions and countries.

This study considers the Diabetes Injection Pens value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Reusable Insulin Pens
Disposable Insulin Pens
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital & Clinic
Retail Pharmacy
Online Sales

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Delfu

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Diabetes Injection Pens consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Diabetes Injection Pens market by identifying its various subsegments.
Focuses on the key global Diabetes Injection Pens manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diabetes Injection Pens with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diabetes Injection Pens submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.